Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pramipexole Augmentation to Target Anhedonia in Depression - a Pilot Study

NCT04121091 is registered in ClinicalTrials.gov with Region Skane as lead sponsor.

NCT NCT04121091
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04121091 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pramipexole Augmentation to Target Anhedonia in Depression - a Pilot Study
Lead sponsor
Region Skane
Phase
Phase 2
Overall status
Completed
Start date
October 4, 2019
Completion date
March 18, 2021
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anhedonia, depression, bipolar, depression, unipolar, dysthymia